A Phase 2, Multicenter, Randomized Study Of Trastuzumab Deruxtecan In Subjects With Her2-Overexpressing Locally Advanced, Unresectable Or Metastatic Colorectal Cancer

Frentzas, Sophia (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Short title	DESTINY-CRC02
Status	Active
Effective start/end date	18/06/21 → 17/06/26

Keywords

phase 2 study
treatment safety
treatment efficacy
colorectal cancer